Bailey Dye

Team science. Ongoing innovation. Brilliant minds. Here’s how The Cancer Genome Atlas spawned a revolution in cancer research and technology.

A new study looks at outcomes for children with leukemia when two tests of remission disagree.

Some subtypes of leukemia have a poor prognosis. Genomic studies are helping to identify these subtypes, leading to targeted therapies.

Understanding the “Three C’s” may provide the insights need to move the needle on the cancers with the bleakest prognoses.